ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,477.90
0.16%
Dow Jones
39,127.80
0.04%
US Dollar vs MXN
18.3363
1.16%
Brent Oil
84.215
0.04%
Bitcoin
60,731.72
-1.75%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sio Gene Therapies Inc (SIOX)

  7. Sio Gene Therapies Inc (SIOX) Noticias

SIOX

Sio Gene Therapies (SIOX)

Sio Gene Therapies Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SIOX
FechaHoraFuenteTítuloSímboloCompañía
02/02/202406:00GlobeNewswire Inc.Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareNASDAQ:SIOXSio Gene Therapies Inc
25/04/202315:05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SIOXSio Gene Therapies Inc
17/04/202315:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SIOXSio Gene Therapies Inc
17/04/202315:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SIOXSio Gene Therapies Inc
12/04/202307:52Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SIOXSio Gene Therapies Inc
06/04/202315:08Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:SIOXSio Gene Therapies Inc
06/04/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
17/03/202305:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SIOXSio Gene Therapies Inc
21/02/202315:06Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SIOXSio Gene Therapies Inc
14/02/202306:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
14/02/202305:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SIOXSio Gene Therapies Inc
13/02/202307:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SIOXSio Gene Therapies Inc
10/02/202315:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SIOXSio Gene Therapies Inc
09/02/202305:01Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SIOXSio Gene Therapies Inc
14/12/202215:49GlobeNewswire Inc.Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNASDAQ:SIOXSio Gene Therapies Inc
10/11/202206:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
11/08/202206:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
14/06/202206:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SIOXSio Gene Therapies Inc
14/06/202206:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
28/04/202208:05TipRanksAnalyst Explains Why They Downgraded Their Rating on Sio Gene Therapies (SIOX)NASDAQ:SIOXSio Gene Therapies Inc
27/04/202215:25GlobeNewswire Inc.Sio Gene Therapies Provides Corporate UpdateNASDAQ:SIOXSio Gene Therapies Inc
11/02/202206:00GlobeNewswire Inc.Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
10/02/202216:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SIOXSio Gene Therapies Inc
02/02/202206:00GlobeNewswire Inc.Sio Gene Therapies to Present at the 18th Annual WORLDSymposium™ 2022NASDAQ:SIOXSio Gene Therapies Inc
31/01/202215:01GlobeNewswire Inc.Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO TransitionNASDAQ:SIOXSio Gene Therapies Inc
12/11/202106:00GlobeNewswire Inc.Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
11/11/202106:00GlobeNewswire Inc.Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s DiseaseNASDAQ:SIOXSio Gene Therapies Inc
01/11/202106:00GlobeNewswire Inc.Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 GangliosidosisNASDAQ:SIOXSio Gene Therapies Inc
21/10/202116:00GlobeNewswire Inc.Sio Gene Therapies Announces Reorganization of R&D GroupNASDAQ:SIOXSio Gene Therapies Inc
21/10/202107:56Dow Jones NewsSio Gene Therapies Gets FDA Fast-Track Designation for AXO-AAV-GM1 in GM1 GangliosidosisNASDAQ:SIOXSio Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:SIOX

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
FX
EURUSD
Euro vs US Dollar
NASDAQ
AAPL
Apple
AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
NYSE
CVX
Chevron
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados